BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6311693)

  • 1. Treatment of reflux oesophagitis with ranitidine.
    Wesdorp IC; Dekker W; Klinkenberg-Knol EC
    Gut; 1983 Oct; 24(10):921-4. PubMed ID: 6311693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine and placebo in the treatment of reflux oesophagitis. A double-blind randomized trial.
    Goy JA; Maynard JH; McNaughton WM; O'Shea A
    Med J Aust; 1983 Nov; 2(11):558-61. PubMed ID: 6314107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
    Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD
    Digestion; 1984; 29(2):119-23. PubMed ID: 6329862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
    Havelund T; Laursen LS; Skoubo-Kristensen E; Andersen BN; Pedersen SA; Jensen KB; Fenger C; Hanberg-Sørensen F; Lauritsen K
    Br Med J (Clin Res Ed); 1988 Jan; 296(6615):89-92. PubMed ID: 3122967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
    Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
    Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
    Lehtola J; Niemelä S; Martikainen J; Krekelä I
    Scand J Gastroenterol; 1986 Mar; 21(2):175-80. PubMed ID: 3520796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
    Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
    Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L
    Digestion; 1990; 47 Suppl 1():72-5. PubMed ID: 2093020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
    Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.
    Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R
    Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
    Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
    Grove O; Bekker C; Jeppe-Hansen MG; Karstoft E; Sanchez G; Axelsson CK; Nielsen HO; Andersen B; Rask-Madsen J
    Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
    Bremner CG; Marks IN; Segal I; Simjee A
    Am J Med; 1991 Aug; 91(2A):119S-122S. PubMed ID: 1882897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisapride versus ranitidine in the treatment of reflux esophagitis.
    Janisch HD; Hüttemann W; Bouzo MH
    Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
    Pace F; Sangaletti O; Bianchi Porro G
    Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflux oesophagitis in heavy drinkers. Effect of ranitidine and alginate/metoclopramide.
    Tønnesen H; Andersen JR; Christoffersen P; Kaas-Claesson N
    Digestion; 1987; 38(2):69-73. PubMed ID: 3440508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.